6^th International Conference on Vascular Dementia Feb 27-Mar 01, 2017 Amsterdam, Netherlands

Conference series LLC invites all the participants from all over the world to attend 6^th International Conference on Vascular Dementia during February 27^th - March 01^st, 2017 at Amsterdam, Netherlands with the Theme: Exploring the challenges concerning excellence in dementia research and care which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Vascular dementia is defined as inadequate blood flow can damage and eventually kill cells anywhere in the body.

In vascular dementia, changes in thinking skills sometimes occur suddenly following strokes that block major brain blood vessels. Vascular brain changes often coexist with changes linked to other types of dementia, including Alzheimer's disease and dementia with Lewy bodies. Vascular dementia symptoms may be most obvious when they happen soon after a major stroke includes confusion, disorientation, trouble speaking or understanding speech and vision loss.

Vascular dementia is the second-most-common type of dementia in the United States and Europe in the elderly, however it is the most common form in some parts of Asia. The incidence of the illness is 1.5% in Western countries and just about 2.2% in Japan. It accounts for 50% of all dementias in Japan, 20% to 40% in Europe and 15% in Latin America. The prevalence of dementia is 9 times higher in patients who have had a stroke than in controls. 25% of stroke patients develop new-onset dementia within 1 year of their stroke. The relative risk of incident dementia is 5.5% within 4 years of suffering a stroke.

The overall multi infarct dementia market is segmented into North America, Asia Pacific, Europe, Latin America and MEA. As of 2014, North America held largest market share in terms of revenue owing to the increasing incidences of multi infarct dementia coupled with increasing geriatric population base. European market displayed similar traits and followed North American multi infarct dementia market. Asia Pacific is expected to grow at a high pace due to increasing awareness about prevention of brain strokes in this region. Japan owing to increased geriatric base represents approximately more than 50% of the dementia cases in Asia Pacific. The developed nations such as Japan, Canada, France, Germany and U.S. are anticipated to witness favourable growth over the forecast period.

Various companies in the multi infarct dementia market are adopting several economical strategies such as collaborations, expansions and acquisitions to keep a strong position and gain advantage in the market. Some major companies in the market include Forest Laboratories, Inc., Janssen Pharmaceuticals, Inc., Novartis Pharmaceutical Corporation, Pfizer, Inc. and Eisai, Inc.

Why to attend ?

Vascular Dementia Conference is a unique forum to bring together worldwide distinguished academics in the field of Neuroscience and Neurology, Nutrition, Researchers, Public health professionals, Scientists, Academic scientists, Industry researchers, Scholars to exchange about state of the Research and Development.

Aim of this conference is stimulate new ideas for treatment that will be beneficial across the spectrum of Vascular Dementia. A Unique Opportunity for Advertisers and Sponsors at this International event.

Target Audience

Business delegates, Industrial Leaders, Vascular Dementia Researchers, Neurologist, Neuroscientist, Neurosurgeons, CEO's and R&D Heads  from Industries, Directors, Psychiatrist, Nutritional Scientists, Head of department, Vascular Dementia Coach, Professors and Students from Academia in the research of vascular dementia.

Vascular Dementia 2017 welcomes attendees, presenters, and exhibitors from all over the world to Amsterdam, Netherlands. We are delighted to invite you all to attend and register for the 6^th International Conference on Vascular Dementia during February 27^th - March 01^st, 2017 at Amsterdam, Netherlands

The organizing committee is gearing up for an exciting and informative   program on a variety of topics, poster presentations and various programs for participants from all over the world. Unsurpassed substantiation cure for Vascular Dementia clearly shows that the close association of families and carers in the care of their loved ones is key to improving early revealing of Vascular Dementia, renewal to a healthy   weight and sustaining long term wellbeing.

This conference will increase knowledge, provide support, assist learning and allow families and carers to seek out applicable services for their loved one and to develop the best possible home environment to support recovery from these complex and devastating diseases.

Vascular dementia, also known as multi-infarct dementia (MID) and vascular cognitive impairment (VCI), is dementia caused by problems in the supply of blood to the brain, typically by a series of minor strokes. Vascular dementia is the second-most-common form of dementia after Alzheimer's disease (AD) in older adults. Vascular dementia is thought to be irreversible and it is caused by a number of small strokes or sometimes a large stroke preceded or followed by other smaller strokes. The term refers to a group of syndromes caused by different mechanisms all resulting in vascular lesions in the brain. Early detection and accurate diagnosis are important, as vascular dementia is at least partially preventable.

Globally, results of a recent meta-analysis suggest that 44 million people lived with dementia worldwide in 2010, with numbers expected to almost double every 20 years, to 65.7 million in 2030 and 115.4 million in 2050. In 2010, 58 per cent of all people with dementia lived in countries with low or middle incomes, with this proportion anticipated to rise to 63 per cent in 2030 and 71 per cent in 2050.This number is expected to double by 2030 and more than triple by 2050 to 115 million.

In the United States alone, experts estimate that as many as five million people age 65 and older suffer from Alzheimer’s disease. 

Dementia is widely considered the second most common cause of dementia after Alzheimer's disease, accounting for 10 per cent of cases. Many experts believe that vascular dementia remains underdiagnosed like Alzheimer's disease even though it's recognized as common.

Alzheimer's Research UK currently funds 150 research projects across the UK and has committed nearly £40million to dementia research.

Their research will focus on improving the quality of life of those already living with Alzheimer’s disease and other forms of dementia.

The Alzheimer's Association funds independent investigators worldwide, they have awarded over $335 million to more than 2,250 projects.

Research conducted by the Alzheimer's Society, shows that there will be 850,000 people living with dementia in the UK by 2015. This will cost the UK £26 billion a year.

Two-thirds (£17.4 billion) of the cost of dementia is paid by people with dementia and their families, either in unpaid care (£11.6 billion) or in paying for private social care. This is in contrast to other conditions, such as heart disease and cancer, where the NHS provides care that is free at the point of use.

Vascular Dementia 2017 will be a platform where you will be sure to have a meaningful experience with scholars from around the world. All members of the Vascular Dementia 2017 organizing committee look forward to meeting you in Amsterdam, Netherland.

Our Conference will provide a perfect platform addressing:

• Laudable talks by the top-notch of the global scientific community

• Sterling workshop sessions

• Remarkable Awards and Global Recognition to meritorious Researchers

• Global Networking with 50+ Countries

• Novel Techniques to Benefit Your Research

• Global Business and Networking Opportunities

• Exquisite Platform for showcasing your products and International Sponsorship

See more at: http://vasculardementia.conferenceseries.com/

Importance and Scope

Vascular dementia Conference is a unique forum to bring together worldwide distinguished academics in the field of Neuroscience and Neurology, Nutrition, Researchers, Public health professionals, Scientists, Academic scientists, Industry researchers, Scholars to exchange about state of the art research and technologies.

Aim of this conference is stimulate new ideas for treatment that will be beneficial across the spectrum of Vascular Dementia. Conferences, National symposiums and Workshops provide a dedicated forum for the advancement, execution and exchange of information about Vascular Dementia and its allied areas.

Why Amsterdam?

Amsterdam is the capital city and most populous city of the Kingdom of the Netherlands.

Its status as the Dutch capital is mandated by the Constitution though it is not the seat of the Dutch government, which is The Hague. As is the case in all the countries with the highest health care expenditures, the Netherlands has an exceptionally strong economy.

The country's GDP per capita was estimated at $41,711 in 2013, higher than all but a handful of OECD nations. The Dutch government paid the vast majority of health care costs, with nearly 86% of all spending coming from public sources in 2012, the highest proportion in the OECD.

Netherlands government allocate EUR 32.5 million to the fight against Neurological disease over the next four years. The Netherlands Organisation for Scientific Research (NWO) provided fund of €550 million to fuel the research on mental illness. NARSAD Young Investigator Grant provides $30,000 per year on research in Neural and behavior disorders such as schizophrenia, mood disorders, anxiety disorders, or child and adolescent mental illnesses.

Amsterdam is currently one of the best European cities in which to locate an international business. It is ranked fifth in this category and is only surpassed by London, Paris, Frankfurt and Barcelona. Many large corporations and banks have their headquarters in Amsterdam, including Akzo Nobel, Heineken International, ING Group, ABNAMRO, TomTom, Delta Lloyd Group and Philips. KPMG International's global headquarters is located in nearby Amstelveen, where many non-Dutch companies have settled as well, because surrounding communities allow full land ownership, contrary to Amsterdam's land-lease system.

Conference Highlights

• Dementia

• Causes and Prevention

• Vascular Dementia

• Ageing and Dementia

• Advances in Dementia Test

• Dementia Stages

• Dementia Care Management

• Vascular Dementia Nursing

• Advanced Drug for Dementia

• Potential Future Interventions

• Neuro-entrepreneurship: Vascular Dementia

• Animal Models and Translational Medicine

Funding Projects

• Alzheimer’s Research UK

• Alzheimer's Association

• Alzheimer's Disease Education and Referral Center (ADEAR)

• National Institute on Aging

• Alzheimer's Foundation of America

• Alzheimer’s Drug Discovery Foundation

• Association for Frontotemporal Degeneration (AFTD)

• BrightFocus Foundation

• John Douglas French Alzheimer's Foundation

• Lewy Body Dementia Association

• National Institute of Mental Health (NIMH)

• National Organization for Rare Disorders (NORD)

• BRACE - Alzheimer's Research

• Alzheimer's Society

• Alzheimer's Society of Canada

Target Audience

• Directors

• Head of Department

• Professors

• Industrial

• Neurologist

• Neuroscientist

• Neurosurgeons

• Psychiatrist

• Nutritional Scientists

• Students from Academia in the research of Neurology, Nutrition

Around 55 associations of Vascular Dementia are there in Netherland.

• Dutch Neurofederation

• International Child Neurology Association

• National Neurological Member Societies

• European Federation of Neurological Associations

• Netherlands Society for Neurosurgery

• European Association of Neurosurgical Societies

• Dutch Society of Child Neurology

• The International Federation of Multiple Sclerosis Societies

• Stroke Association

• Brain Injury Rehabilitation Trust

• National Neurological Member Societies

• Alzheimer's Society

• Migraine Trust

• International Headache Society

• Huntington's disease Association

• Brain tumor organizations

• National Brain Tumor Society

• European Federation of neurological societies

• The World Federation of Neurology

• National Association for Mental Health  

Top universities 500 globally working in the field of Vascular Dementia.

• Harvard University

• University College London

• University of California--San Francisco

• Stanford University

• Massachusetts Institute of Technology

• Johns Hopkins University

• University of California--Los Angeles

• University of California--San Diego

• Columbia University

• University of Oxford

• University of Cambridge

• Yale University

• University of Pennsylvania

• University of Toronto

• Washington University in St. Louis

• New York University

• McGill University

• King's College London

• Karolinska Institute

• California Institute of Technology

There are around 200 universities in Netherland which are working in the field of Vascular Dementia.

• Radboud University

• Maastricht University, Faculty of Psychology and Neuroscience

• University of Amsterdam

• Leiden University

• University College Utrecht

• University of Groningen

• Utrecht University

• University Medical Center Groningen

• VU University Amsterdam

• Maastricht University

• University Medical Center Utrecht

• Leids University Medisch Centrum

Top Hospitals Associated with Vascular Dementia Research in World.

• John Hopkins Medicine

• Massachusetts General Hospital

• Siloam Hospitals

• Mayo Clinic

• The Mount Sinai Hospital

• Jefferson Hospital for Neuroscience

• Neurology Florida Hospital

• UNM Neurology Centre

• Tampa General Hospital

• Huntington Hospital

• EI Camino Hospital

There are above 500 Companies Associated with Vascular Dementia Research in World.

• Forest Laboratories

• Janssen Pharmaceuticals

• Novartis Pharmaceutical Corporation

• Pfizer

• Eisai

• Actinogen Limited

• Alector LLC

• AlzProtect SAS

• TauRx Therapeutics Ltd

• Pacific Northwest Biotechnology

• Tautatis Incorporated

References

http://www.rsc.org/chemistryworld/2014/07/asd

http://www.usnews.com/education/best-global-universities/neuroscience-behavior?page=2

http://www.thecompleteuniversityguide.co.uk/search/?q=amsterdam

http://www.brainandspine.org/neurological-centres-in-the-Netherlands

https://www.google.co.in/search?q=HOSPITALS+IN+UK&ie=utf-8&oe=utf-8&aq=t&rls=org.

http://en.wikipedia.org/wiki/List_of_pharmaceutical_manufacturers_in_the_Netherlands

http://www.iamexpat.nl/expat-page/healthcare/general-practitioners-gp-doctors-netherlands

http://www.grandviewresearch.com/industry-analysis/multi-infarct-dementia-market

http://www.transparencymarketresearch.com/multi-infarct-dementia-market.html

https://en.wikipedia.org/wiki/Vascular_dementia